Revolution Medicines, Inc. (RVMD) Net income 2018–2025
Revolution Medicines, Inc. (RVMD) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$1.1BFY2025 · since FY2018: -$41.8M → -$1.1B
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$1.1B | -88.5% |
| FY2024 | -$600.1M | -37.5% |
| FY2023 | -$436.4M | -75.5% |
| FY2022 | -$248.7M | -32.9% |
| FY2021 | -$187.1M | -73.0% |
| FY2020 | -$108.2M | -126.9% |
| FY2019 | -$47.7M | -14.1% |
| FY2018 | -$41.8M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More RVMD financial trends
RVMD RevenueRVMD Net marginRVMD Gross profitRVMD Gross marginRVMD Operating incomeRVMD Operating marginRVMD Operating cash flowRVMD Free cash flowRVMD Capital expendituresRVMD Return on equityRVMD Stock buybacksRVMD Dividends paidRVMD Total assetsRVMD Total liabilitiesRVMD Shareholders’ equityRVMD overview →